NEW HAVEN, Conn. and MONMOUTH JUNCTION, N.J., Nov. 28, 2022 /PRNewswire/ — DiamiR, a developer of innovative blood-based diagnostic tests for brain health and other diseases, today announced that it will present a poster at the 15th Clinical Trials on Alzheimer’s Disease (CTAD), taking place November 29 – December 2, 2022, at the Hilton Union Square in San Francisco, CA, and online.

Title: Association of circulating brain-enriched microRNAs with demographic and clinical factors in A4 screening plasma samples from cognitively normal individuals
Session Title: Clinical trials: Biomarkers including plasma
Poster Number: LP67
Date and Time: Thursday, December 1, 8 am – 6 pm PT